PLSE (Pulse Biosciences) Total Assets: $81.62 Mil (As of Mar. 2026)


PLSE Pulse Biosciences Inc PLSE
31 GF Score
Price $28.38
! 3 Warning Signs
View Full Analysis

What is Pulse Biosciences Total Assets?

Pulse Biosciences PLSE +3.42% 31 Total Assets is $81.62 Mil as of Mar. 2026. GuruFocus rates PLSE with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

Pulse Biosciences's Total Assets for the quarter that ended in Mar. 2026 was $81.62 Mil.

During the past 12 months, Pulse Biosciences's average Total Assets Growth Rate was -5.70% per year. During the past 3 years, the average Total Assets Growth Rate was -6.20% per year. During the past 5 years, the average Total Assets Growth Rate was -10.60% per year. During the past 10 years, the average Total Assets Growth Rate was 4.40% per year.

During the past 12 years, Pulse Biosciences's highest 3-Year average Total Assets Growth Rate was 32.40%. The lowest was -17.40%. And the median was 1.00%.

Total Assets is connected with ROA %. Pulse Biosciences's annualized ROA % for the quarter that ended in Mar. 2026 was -84.38%. Total Assets is also linked to Revenue through Asset Turnover. Pulse Biosciences's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Pulse Biosciences  (NAS:PLSE) Total Assets Explanation

Total Assets is connected with ROA %.

Pulse Biosciences's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-74.324/( (94.539+81.622)/ 2 )
=-74.324/88.0805
=-84.38 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Pulse Biosciences's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0.401/( (94.539+81.622)/ 2 )
=0.401/88.0805
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Pulse Biosciences Total Assets Related Terms

Pulse Biosciences Total Assets Historical Data

* Premium members only.

The historical data trend for Pulse Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulse Biosciences Total Assets Chart

Pulse Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.25 77.88 59.15 132.46 94.54

Pulse Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 133.38 120.25 108.77 94.54 81.62
PLSE
31GF Score
Pulse Biosciences Inc PLSE
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pulse Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Pulse Biosciences's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=80.656+13.883
=94.54

Pulse Biosciences's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=66.298+15.324
=81.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $81.62 Mil mean?
Pulse Biosciences (PLSE) has a Total Assets of $81.62 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Pulse Biosciences and its competitors.
Is Pulse Biosciences' Total Assets too high?
Pulse Biosciences' current Total Assets is $81.62 Mil. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' Total Assets compare to NNNN and STAA?
Pulse Biosciences' Total Assets of $81.62 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Pulse Biosciences and its competitors. Pulse Biosciences's current Total Assets is $81.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (PLSE) has a current Total Assets of $81.62 Mil. The current Total Assets is $81.62 Mil. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Pulse Biosciences (PLSE), the current Total Assets is $81.62 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pulse Biosciences Business Description

Other Exchanges 6L8:Germany
Address 601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score

Get the complete analysis for PLSE

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.38
Price